Agilent Technologies Inc.
(
A
) launched real-time spectrum analysis (RTSA) for use with its
PXA X-Series signal analyzers.
The real time spectrum is required for analysis of properties
of matter in an electromagnetic state, bandwidth, sensitivity and
frequency range. System developers and signal analysts require
this study to understand various signal qualities and to check
for any abnormalities in the signal strength present or not.
Agilent's RTSA will be particularly useful in applications
such as radar, electronic warfare and military communications,
since the study of the signal strength is crucial for these
applications. Hence, these new real-time spectrum analyses will
likely offer the most accurate measurement.
Further, for more in-depth analysis, the RTSA can be used with
Agilent's 89600 VSA software. The combination of the spectrum
analyzer with the software will enable system developers and
signal analysts to locate the cause of signal problems so that
real time signals do not get disrupted, which can be critical in
some situations.
Thus, Agilent's continued drive toward a steady flow of new
products may prove to be beneficial as the study of signal
quality and spectrum analysis is becoming quite crucial.
Agilent's revenue in the third quarter was flat sequentially
and up 1.9% year over year, short of management's expectations of
a 2-3% sequential increase ($1.77 billion to $1.79 billion). The
newly added Diagnostics and Genomics segment accounted for 9.0%
of revenues in the last quarter, up 47.2% sequentially.
Currently, Agilent Technologies has a Zacks Rank #3 (Hold).
Other test equipment companies, which are currently better
positioned include
National Instruments Corporation
(
NATI
), with a Zacks Rank #1 (Strong Buy) and
Ametek Inc.
(
AME
) and
On Semiconductor
(
ONNN
), with a Zacks Rank #2 (Buy).
AGILENT TECH (A): Free Stock Analysis Report
AMETEK INC (AME): Free Stock Analysis Report
NATL INSTRS CP (NATI): Free Stock Analysis
Report
ON SEMICON CORP (ONNN): Free Stock Analysis
Report
To read this article on Zacks.com click here.
Zacks Investment
Research